NeuroproteXeon is a late clinical-stage pharmaceutical company developing the proprietary use of xenon gas, delivered via a patented inhalation device, to protect against brain cell death following acute neurologic injury. NP is currently preparing for a Phase III Clinical Trial in Out of Hospital Cardiac Arrest (OHCA).
Company Details
- Employees
- 3
- Founded
- 2015
- Address
- 50 Cobham Drive, Orchard Park,ny 14127,united States
- Phone
- (716) 332-7200
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- neuroprotexeon.com
- HQ
- Orchard Park, NY
Neuroprotexeon Questions
Neuroprotexeon's helpline number is (716) 332-7200
Neuroprotexeon's website is neuroprotexeon.com
Neuroprotexeon's LinkedIn profile is https://www.linkedin.com/company/neuroprotexeon
Neuroprotexeon has
3 employees.
View email and phone details for 3
employees at Neuroprotexeon.
Neuroprotexeon's industry is
Pharmaceutical Manufacturing
Neuroprotexeon's top competitors are
Okapi Chemtech, Inc.,
New Bedford Panoramex,
Nenupharma Lsc,
New Life Drug Rehab Centers,
Nutragy,
Invero Pharma,
Nipomo Rexall Drug,
Niche Pharmaceuticals Inc,
New Century Pharmaceuticals, Inc.,
Nomads Loom Inc.
Neuroprotexeon's categories are Pharmaceutical Manufacturing
Neuroprotexeon's founding year is 2015
